ArticleJCO precision oncology2024

Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.

Manuela Hummel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.